» Articles » PMID: 33332235

Temporal Changes in Targeted Temperature Management for Out-of-Hospital Cardiac Arrest-Examining the Effect of the Targeted Temperature Management Trial: A Retrospective Cohort Study

Overview
Date 2020 Dec 17
PMID 33332235
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Targeted temperature management (TTM) is recommended after out-of-hospital cardiac arrest (OHCA). However, interpretation of the evidence and translation into clinical practice, to realize benefits to patient outcomes may be inconsistent. This study aims to compare compliance with the recommended targeted temperatures and the use of intravascular temperature management (IVTM), as well as 90-day survival, before and after publication of the TTM trial. A single-center retrospective cohort study was conducted from 2010 to 2017. All comatose patients admitted to the intensive care unit after OHCA, who survived for ≥24 hours, were included. IVTM use was measured and TTM adherence was defined as the percentage time the core temperature was (1) within the guideline-recommended temperature range (initially 32-34°C, later modified to 32-36°C) for the first 24 hours, and (2) ≤37.5°C between 24 and 72 hours following admission. Multiple logistic regression analyses were performed for the use of IVTM and survival at 90 days. Of the 302 patients identified, 136 (45%) were pre-TTM, and 166 (55%) post-TTM. Baseline characteristics were similar between the groups. IVTM use decreased significantly (77.9% vs. 51.8%,  < 0.001) after the publication of the TTM trial. Adherence to the 32-34°C and 32-36°C targets was higher pre-TTM as compared with the post-TTM cohort (33.3% [0-66.7%] vs. 0% [0-16.7%],  < 0.001 and 83.3% [50.0-100%] vs. 36.7% [16.7-66.7%],  < 0.001, respectively). Time with temperature ≥37.5°C in the first 24 hours was higher post-TTM ( = < 0.001) but not between 24 and 72 hours. Ninety-day survival was 54.4% in the pre-TTM cohort and 44.0% post-TTM, (odds ratio 1.52 [0.96-2.40],  = 0.083). Adherence with recommended TTM decreased significantly following publication of the TTM trial and this was explained by a significant decrease in IVTM use. However, this concerning trend did not result in a statistically significant difference in survival.

Citing Articles

The role of targeted temperature management in 30-day hospital readmissions in cardiac arrest survivors: A national population-based study.

Mark J, Lopez J, Wahood W, Dodge J, Belaunzaran M, Losiniecki F Int J Cardiol Heart Vasc. 2023; 46:101207.

PMID: 37113651 PMC: 10127122. DOI: 10.1016/j.ijcha.2023.101207.


Clinical Outcomes with Targeted Temperature Management (TTM) in Comatose Out-of-Hospital Cardiac Arrest Patients-A Retrospective Cohort Study.

Scholte N, van Wees C, Rietdijk W, van der Graaf M, Jewbali L, van der Jagt M J Clin Med. 2022; 11(7).

PMID: 35407394 PMC: 8999846. DOI: 10.3390/jcm11071786.


Brain death: a clinical overview.

Spears W, Mian A, Greer D J Intensive Care. 2022; 10(1):16.

PMID: 35292111 PMC: 8925092. DOI: 10.1186/s40560-022-00609-4.


Target temperature management following cardiac arrest: a systematic review and Bayesian meta-analysis.

Aneman A, Frost S, Parr M, Skrifvars M Crit Care. 2022; 26(1):58.

PMID: 35279209 PMC: 8917746. DOI: 10.1186/s13054-022-03935-z.


[Targeted temperature management after cardiac arrest : What is new?].

Kainz E, Fischer M Anaesthesist. 2022; 71(2):85-93.

PMID: 35050390 DOI: 10.1007/s00101-022-01091-1.